Whereas, antibodies purified from prostate cancer patients appear to induce cell proliferation [11–13], GRP78 antibodies purified from ovarian cancer patients increase apoptosis and decrease invasive characteristics [15]. This evidence concerns the gene HSPA5 and prostate cancer.